Funding for this research was provided by:
National Cancer Institute (P01-CA073992, P30-CA42014)
Huntsman Cancer Foundation
National Center for Advancing Translational Sciences (1ULTR001067)
Received: 12 March 2018
Accepted: 2 July 2018
First Online: 16 July 2018
Ethics approval and consent to participate
: All aspects of this study were approved by University of Utah’s Institutional Review Board for human subject research. All patients participating gave written informed consent and authorization for use of data.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.